Show simple item record

Delta-1: a global, multicenter, phase 2 study of Itil-168, an unrestricted autologous tumorinfiltrating lymphocyte (Til) cell therapy, in adult patients with advanced cutaneous melanoma

dc.contributor.authorGastman, B.
dc.contributor.authorSarnaik, A.
dc.contributor.authorLawrence, D.
dc.contributor.authorOlszanski, A.
dc.contributor.authorChmielowski, B.
dc.contributor.authorLutzky, J.
dc.contributor.authorButler, M.
dc.contributor.authorHamid, O.
dc.contributor.authorCorrie, P.
dc.contributor.authorDomingo-Musibay, E.
dc.contributor.authorThomas, S.
dc.contributor.authorThistlethwaite, Fiona C
dc.contributor.authorDaniels, G.
dc.contributor.authorEvans, T.
dc.contributor.authorFurness, A.
dc.contributor.authorGibney, G.
dc.contributor.authorHarries, M.
dc.contributor.authorMedina, T.
dc.contributor.authorOlson, D.
dc.contributor.authorPallan, L.
dc.contributor.authorWhitman, E.
dc.contributor.authorWilson, M.
dc.contributor.authorAycock, J.
dc.contributor.authorHawkins, R.
dc.contributor.authorJiang, Y. Z.
dc.contributor.authorKennedy, A.
dc.contributor.authorRobbins, P.
dc.contributor.authorRoberts, Z.
dc.contributor.authorLe Gall, J.
dc.date.accessioned2023-05-17T09:50:55Z
dc.date.available2023-05-17T09:50:55Z
dc.date.issued2022en
dc.identifier.citationGastman B, Sarnaik A, Lawrence D, Olszanski A, Chmielowski B, Lutzky J, et al. Delta-1: A Global, Multicenter, Phase 2 Study of Itil-168, an Unrestricted Autologous Tumorinfiltrating Lymphocyte (Til) Cell Therapy, in Adult Patients with Advanced Cutaneous Melanoma. Journal for immunotherapy of cancer. 2022 Nov;10:A819-A. PubMed PMID: WOS:000919423400743.en
dc.identifier.doi10.1136/jitc-2022-SITC2022.0787en
dc.identifier.urihttp://hdl.handle.net/10541/626280
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1136/jitc-2022-SITC2022.0787en
dc.titleDelta-1: a global, multicenter, phase 2 study of Itil-168, an unrestricted autologous tumorinfiltrating lymphocyte (Til) cell therapy, in adult patients with advanced cutaneous melanomaen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentCleveland Clinic, Cleveland, OH,en
dc.identifier.journalJournal for Immunotherapy of Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record